Leaflet REMERON SOLTAB 30mg dispersible tablets
Indicated for: depression
Route of administration: oral
Substance: mirtazapine (antidepressant)
ATC: N06AX11 (Nervous system | Antidepressants | Other antidepressants)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Seek medical help if suicidal thoughts or major behavior changes occur.
Do not stop treatment abruptly without medical advice.
This medicine may cause drowsiness or reduced alertness.
Mirtazapine is an antidepressant medication used for the treatment of major depression and other mood disorders. It works by increasing levels of serotonin and norepinephrine in the brain, thereby improving mood and reducing depressive symptoms.
The medication is taken orally, usually once daily at bedtime. It is effective in alleviating depressive symptoms and improving sleep quality.
Side effects may include drowsiness, weight gain, dry mouth, and dizziness. In rare cases, severe reactions such as suicidal thoughts or worsening depression may occur. Close monitoring is essential, especially at the beginning of treatment.
Consult your doctor to discuss the benefits and risks of treatment with Mirtazapine. Follow the prescribed dosage and adhere to all medical recommendations.
General data about REMERON SOLTAB 30mg
- Substance: mirtazapine
- Date of last drug list: 01-03-2022
- Commercial code: W12823003
- Concentration: 30mg
- Pharmaceutical form: dispersible tablets
- Quantity: 30
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Pharmaceutical forms available for mirtazapine
Concentrations available for mirtazapine
- 15mg
- 30mg
- 45mg